Skip to main content
. 2023 Jan 11;12(1):33–57. doi: 10.21037/tau-22-663

Figure 5.

Figure 5

Two potential upstream miRNAs of SLC7A11 in RCC from the starBase database. (A) The expression of miR-26b-5p in KIRP and normal tissues; (B) the expression of miR-27b-3p in KIRP and normal tissues; (C) the expression of miR-32-5p in KIRP and normal tissues; (D) the expression of miR-363-3p in KIRP and normal tissues; (E) the overall survival for miR-26a-5p in KICH; (F) the overall survival for miR-27b-3p in KIRC; (G) the overall survival for miR-27b-3p in KIRP; (H) the correlation of miR-26a-5p with SLC7A11 expression in KICH; (I) the correlation of miR-27b-3p with SLC7A11 expression in KIRC; (J) the correlation of miR-27b-3p with SLC7A11 expression in KIRP. *P<0.05; ***P<0.001. RCC, renal cell carcinoma; KIRP, kidney renal papillary cell carcinoma; KICH, kidney chromophobe cell carcinoma; KIRC, kidney renal clear cell carcinoma.